Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|October 17, 2008
FLT3 inhibitors for the treatment of autoimmune diseaseKatharine A Whartenby, Donald Small, Peter A CalabresiInternational Journal of Hematologic Oncology|October 11, 2018
Potential role for all-<i>trans</i> retinoic acid in nonpromyelocytic acute myeloid leukemiaHayley S Ma, Tara M Robinson, Donald SmallBlood|September 3, 2010
Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapyJinshui Fan, Li Li, Donald Small, et al.Blood|May 6, 2004
In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effectsMark Levis, Rosalyn Pham, B Douglas Smith, et al.Blood|March 2, 2010
Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AMLThomas A Paul, Juraj Bies, Donald Small, et al.Blood|May 5, 2009
Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twinMeredith K Chuk, Emily McIntyre, Donald Small, et al.Leukemia Research|December 5, 2003
Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AMLRui Zheng, Kendra Klang, Norbert C Gorin, et al.Blood|September 13, 2011
Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin miceLi Li, Emily Bailey, Sarah Greenblatt, et al.Haematologica|April 13, 2019
FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathwaysMin Wu, Li Li, Max Hamaker, et al.Blood|September 18, 2004
FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expressionPatrick Brown, Mark Levis, Sheila Shurtleff, et al.Pageof 9